Associations between paraoxonase-1 and systemic lupus erythematosus

Area of Science:

• Immunology
• Genetics
• Biochemistry

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex etiology.
• Paraoxonase-1 (PON1) is an enzyme with antioxidant and anti-inflammatory properties, potentially influencing SLE pathogenesis.
• Genetic variations in the PON1 gene may affect its activity and susceptibility to autoimmune diseases.

Purpose of the Study:

• To investigate the association between paraoxonase-1 (PON1) levels, specific gene polymorphisms (Q192R and L55M), and systemic lupus erythematosus (SLE).

Main Methods:

• A meta-analysis was conducted on published studies examining PON1 levels and PON1 gene polymorphisms (Q192R and L55M) in SLE patients and healthy controls.
• Data from nine articles were synthesized to evaluate overall associations and ethnicity-specific effects.

Main Results:

• The meta-analysis revealed significantly decreased PON1 levels in SLE patients compared to controls (SMD = -1.626, p = 0.008).
• Ethnicity-specific analyses suggested a tendency towards reduced PON1 activity in European lupus patients (SMD = -1.236, p = 0.083) and confirmed reduced activity in Arab and African populations.
• A significant association was found between the PON1 55M allele and SLE in the Arab population, while no association was observed for the PON1 192R allele.

Conclusions:

• Reduced paraoxonase-1 (PON1) activity is associated with systemic lupus erythematosus (SLE).
• The PON1 L55M gene polymorphism may play a role in SLE susceptibility, particularly within the Arab ethnic group.
• Further research is warranted to elucidate the precise role of PON1 in SLE pathogenesis and its ethnic variations.